Research suggests a shorter 5-day antibiotic regimen for childhood community-acquired pneumonia, instead of 10 days, can optimize treatment efficacy while reducing unnecessary antibiotic use. Although ...

Treatment failure in patients with severe community-acquired pneumonia and high inflammatory response may be reduced when patients also receive corticosteroid treatment, according to a study published ...

Announcing a new publication for Acta Materia Medica journal. The objective of this study was to systematically evaluate the clinical efficacy of the complementary use of corticosteroids in the ...

Omadacycline has a high clinical success rate for treating community-acquired bacterial pneumonia (CABP), according to results of a study presented at IDWeek 2025, held from October 19 to 22, in ...

The addition of steroids to standard care significantly reduces the risk for death in adults with community-acquired ...

The real-world study adds to previous randomized controlled trial findings suggesting that shorter courses of antibiotic therapy can be sufficient for hospitalized patients with mild or moderate ...

Please provide your email address to receive an email when new articles are posted on . Hydrocortisone use was linked to lower risk ratios for all-cause mortality in a systematic review and ...

Adjunctive glucocorticoids may reduce mortality among patients with severe community-acquired pneumonia (CAP) in ...

The results are likely to be more relevant to patients in sub-Saharan Africa than to those in high-resource settings, the ...

Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing ...

Biotest AG (($GB:0N70)) announced an update on their ongoing clinical study. Biotest AG is conducting a Phase III clinical trial titled A ...

In a new study, most patients with community-acquired pneumonia did not receive testing for influenza, even during influenza season, researchers reported in Chest. “Other than CDC surveillance data, ...